1. Home
  2. VIAV vs RGEN Comparison

VIAV vs RGEN Comparison

Compare VIAV & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Viavi Solutions Inc.

VIAV

Viavi Solutions Inc.

HOLD

Current Price

$41.07

Market Cap

7.7B

Sector

Technology

ML Signal

HOLD

Logo Repligen Corporation

RGEN

Repligen Corporation

HOLD

Current Price

$119.10

Market Cap

6.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VIAV
RGEN
Founded
1923
1981
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.7B
6.6B
IPO Year
1996
1995

Fundamental Metrics

Financial Performance
Metric
VIAV
RGEN
Price
$41.07
$119.10
Analyst Decision
Strong Buy
Buy
Analyst Count
8
11
Target Price
$24.79
$172.91
AVG Volume (30 Days)
5.4M
858.8K
Earning Date
04-30-2026
04-28-2026
Dividend Yield
N/A
N/A
EPS Growth
225.00
286.96
EPS
N/A
0.86
Revenue
$1,084,300,000.00
$141,236,000.00
Revenue This Year
$37.78
$14.30
Revenue Next Year
$10.64
$14.52
P/E Ratio
N/A
$133.93
Revenue Growth
8.39
35.10
52 Week Low
$8.10
$109.66
52 Week High
$38.43
$175.77

Technical Indicators

Market Signals
Indicator
VIAV
RGEN
Relative Strength Index (RSI) 67.81 47.70
Support Level $26.56 $112.05
Resistance Level N/A $131.81
Average True Range (ATR) 2.93 4.65
MACD 0.41 1.39
Stochastic Oscillator 93.86 70.98

Price Performance

Historical Comparison
VIAV
RGEN

About VIAV Viavi Solutions Inc.

Viavi Solutions Inc. is an international provider of network test, monitoring, and assurance solutions to communications service providers, enterprises, network equipment manufacturers, civil government, military and avionics customers. The company also offers high-performance thin-film optical coatings, providing light management solutions to anti-counterfeiting, 3D sensing, electronics, automotive, defense, and instrumentation markets. Its operating segments include Network Enablement, Service Enablement, and Optical Security and Performance Products. Geographically, it derives a majority of its revenue from the United States. Additionally, it manufactures and sells optical filters for 3D sensing products that allow facial recognition security authentication for mobile devices.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia Pacific contribute about 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: